Evidence map›Paper›PMID 39223831›Full record

ArticleFEBS open bio2024

Optogenetic control of early embryos labeling using photoactivatable Cre recombinase 3.0.

Kumi Morikawa, Akira Nagasaki, Lue Sun, Eihachiro Kawase, Tatsuhiko Ebihara, Yasuaki Shirayoshi

Abstract read
In one paragraph

Article in FEBS open bio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kumi MorikawaCellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Japan.ORCID https://orcid.org/0009-0005-8574-9516
Akira NagasakiBiomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Japan.ORCID https://orcid.org/0000-0002-1468-4592
Lue SunHealth and Medical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Japan.
Eihachiro KawaseInstitute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.ORCID https://orcid.org/0000-0002-8285-5971
Tatsuhiko EbiharaBiomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Japan.
Yasuaki ShirayoshiDivision of Regenerative Medicine and Therapeutics, Department of Genomic Medicine and Regenerative Therapy, Faculty of Medicine, Tottori University, Yonago, Japan.

Funding

JSPS KAKENHI JP22K06072JST ACT-X JPMJAX201HThe Cooperative Research Program (Joint Usage/Research Center Program) of the Institute for Frontier Life and Medical Sciences, Kyoto UniversityThe Nakajima FoundationThe Research Foundation for Opto-Science and TechnologyThe Uehara Memorial Foundation
6 · The paper itself

Abstract

Establishing a highly efficient photoactivatable Cre recombinase PA-Cre3.0 can allow spatiotemporal control of Cre recombinase activity. This technique may help to elucidate cell lineages, as well as facilitate gene and cell function analysis during development. This study examined the blue light-mediated optical regulation of Cre-loxP recombination using PA-Cre3.0 transgenic early mouse pre-implantation embryos. We found that inducing PA-Cre3.0 expression in the heterozygous state did not show detectable recombination activation with blue light. Conversely, in homozygous embryos, DNA recombination by PA-Cre3.0 was successfully induced by blue light and resulted in the activation of the red fluorescent protein reporter gene, while almost no leaks of Cre recombination activity were detected in embryos without light illumination. Thus, we characterize the conditions under which the PA-Cre3.0 system functions efficiently in early mouse embryos. These results are expected to provide a new optogenetic tool for certain biological studies, such as developmental process analysis and lineage tracing in early mouse embryos.

Indexed as

IntegrasesMice, TransgenicOptogeneticsAnimalsEmbryo, MammalianFemaleLightLuminescent ProteinsMiceRecombination, GeneticRed Fluorescent ProteinCre recombinaseIntegrasesLuminescent ProteinsRed Fluorescent ProteinCre‐loxP recombinationearly embryoslineage tracingoptical regulationoptogeneticsphotoactivatable Cre recombinase

Identifiers

PMID39223831
PMCPMC11532978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.